{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/trigeminal-neuralgia/have-i-got-the-right-topic/","result":{"pageContext":{"chapter":{"id":"6ebb1131-0f9c-5613-9b6d-c44044dc3d59","slug":"have-i-got-the-right-topic","fullItemName":"Have I got the right topic?","depth":1,"htmlHeader":"<!-- begin field 4136f1ad-51f9-4a99-b8bc-ae04a741258d --><h1>Have I got the right topic?</h1><!-- end field 4136f1ad-51f9-4a99-b8bc-ae04a741258d -->","summary":null,"htmlStringContent":"<!-- begin item 8082cb1e-d36e-406e-9b05-b262176b5948 --><!-- begin field d024fd32-e7e4-4c67-8398-acbd00880790 --><p>From age 18 years onwards.</p><!-- end field d024fd32-e7e4-4c67-8398-acbd00880790 --><!-- begin field 8b4c2af0-0602-4987-9ded-f79f3d00f09c --><p>This CKS topic covers the management of trigeminal neuralgia in adults (excluding pregnant or breastfeeding women).</p><p>This CKS topic does not cover the management of other causes of facial pain, including trigeminal neuropathic pain (also called atypical odontalgia).</p><p>There are separate CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/migraine/\">Migraine</a>, <a class=\"topic-reference external-reference\" href=\"/topics/neuropathic-pain-drug-treatment/\">Neuropathic pain - drug treatment</a>, <a class=\"topic-reference external-reference\" href=\"/topics/palliative-cancer-care-pain/\">Palliative cancer care - pain</a>, <a class=\"topic-reference external-reference\" href=\"/topics/post-herpetic-neuralgia/\">Post-herpetic neuralgia</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/shingles/\">Shingles</a>.</p><p>The target audience for this CKS topic is healthcare professionals working within the NHS in the UK, and providing first contact or primary healthcare.</p><!-- end field 8b4c2af0-0602-4987-9ded-f79f3d00f09c --><!-- end item 8082cb1e-d36e-406e-9b05-b262176b5948 -->","topic":{"id":"b411a210-e8ef-56d4-8840-714bb3ca8b7d","topicId":"dd0f36c2-b31b-42ca-bc80-17ddb7e243ec","topicName":"Trigeminal neuralgia","slug":"trigeminal-neuralgia","lastRevised":"Last revised in January 2018","chapters":[{"id":"5a46b0ae-84bb-5e91-9f06-d82e7de90660","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6ebb1131-0f9c-5613-9b6d-c44044dc3d59","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"04895c32-0679-538d-bd7f-566f3b1aca33","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"064b944d-9f86-5ad2-bdde-418e427a69cf","slug":"changes","fullItemName":"Changes"},{"id":"215b2ed2-a6ff-5053-b74a-72ca907fbb6f","slug":"update","fullItemName":"Update"}]},{"id":"0d57219c-f171-59f5-b932-8cabc9dd5049","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"d78c8e6b-affd-55c5-8e55-1db5bbe57261","slug":"goals","fullItemName":"Goals"},{"id":"135b5ce1-adf5-5fa9-8d6a-a90e64183628","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2dd53a4e-0dcf-5797-90d1-ac0ae3a56a93","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a8fd6b61-b1c3-538d-b032-872f1d3427c2","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"7d867bfa-0e88-5dbe-85c4-50f28d24c9c8","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"38f48973-5497-53e5-a936-4b59cbd4b662","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ff1b2d66-75ed-51c6-bfa9-fcc0ad6d6bac","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2e9fdd75-4a7e-56ad-8c9d-02ac90da26bd","slug":"definition","fullItemName":"Definition"},{"id":"4dc2aba7-3510-51d4-9aab-2596d348bd1a","slug":"causes","fullItemName":"Causes"},{"id":"6e2bbd60-dabb-5cdb-86d0-29bd0a23615b","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"7c45985c-eb6e-5f96-9d9b-44cc50b51476","slug":"prevalence","fullItemName":"Prevalence"},{"id":"16848fcb-77c6-5043-9c84-eadffb6ff3aa","slug":"prognosis","fullItemName":"Prognosis"},{"id":"a7f1ea99-b3b5-5e53-952d-515327e12d83","slug":"complications","fullItemName":"Complications"}]},{"id":"5c22d7af-254a-51f1-a8b9-07efa299f48b","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"bbf28df3-9b64-5c32-85b5-26dc3c2cc0af","slug":"diagnosis","fullItemName":"Diagnosis"}]},{"id":"feea47e1-4766-5814-8cd9-3adf7df4600f","fullItemName":"Management","slug":"management","subChapters":[{"id":"5008bdc5-02f7-558d-9c72-fa0bd4f2c01a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"ff7b11db-4087-5134-804a-f231a32cf2ce","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"74b691ce-0764-54e6-a932-11f0755c3089","slug":"carbamazepine","fullItemName":"Carbamazepine"}]},{"id":"ae57d488-a470-558c-b5d7-81fb47f8fbad","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"90e907d0-34e8-53cc-a9f6-53b0de5c633c","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c39bcb69-119d-5f65-927c-00c82813d6f3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"614a98b5-320e-5735-b0f4-c72808b83068","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"4c55bb70-6e39-5673-898f-4244d6e219e7","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"5b8a3490-a3c6-565b-9f06-fc347a6c2eb4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"12e3df2a-fa39-57fa-b4ef-e222cd41fa5b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"d1abb506-cecf-562c-84a9-1e2167e7129f","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}